Roger Bate

TL;DR: The high persistence of substandard drugs and clinically inappropriate artemisinin monotherapies in the private sector risks patient safety and, through drug resistance, places the future of malaria treatment at risk globally.

TL;DR: A global treaty is proposed to overcome the problems of substandard and falsified medicines and safeguard the quality of genuine medicine and criminalise falsified ones.

TL;DR: In this article, a range of antimalarial drugs were procured from private pharmacies in urban and peri-urban areas in the major cities of six African countries, situated in the part of that continent and the world that is most highly endemic for malaria.

TL;DR: It is argued that public health should be the prime consideration in defining and combating counterfeit medicines, and that the World Health Organization should take a more prominent role in the fight against counterfeit medicines.

TL;DR: The prevalence of substandard drugs in Delhi and Chennai is confirmed to be roughly in accordance with the Indian government's current estimates, but important spatial and product heterogeneity exists, which suggests that India's substandard drug problem is not ubiquitous, but driven by a subset of manufacturers and pharmacies which thrive in an inadequately regulated environment.